跳至主要内容
临床试验/NCT05614284
NCT05614284终止不适用

A Prospective, Post-Market, Multicenter Comparative Analysis of the Efficacy of Virtuos and Autograft Bone Graft in Lumbar Fusion Surgery

Orthofix Inc.6 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2022年11月14日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
Orthofix Inc.
入组人数
6
试验地点
6
主要终点
Successful Fusion

研究概览

简要总结

Compare the lumbar fusion rates at 12 and 24 months when lumbar arthrodesis is performed using Virtuos or Autograft Bone Graft. Surgical approach is limited to TLIF (MIS or Open) with posterior fixation and supplemental posterolateral fusion as directed by physician, but must comply with FDA approved/cleared indication for use and labeling.

详细描述

The purpose of this study is to compare clinical and radiographic outcomes in patients undergoing transforaminal lumbar interbody fusion (minimally invasive or open) with either Virtuos bone graft or autograft/allograft bone graft.

Compare the lumbar fusion rates at 12 and 24 months when lumbar arthrodesis is performed using Virtuos or Autograft Bone Graft. Surgical approach is limited to TLIF (MIS or Open) with posterior fixation and supplemental posterolateral fusion as directed by physician, but must comply with FDA approved/cleared indication for use and labeling.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inclusion criteria:
  • At least 18 years of age at the time of surgery
  • Undergoing lumbar spine fusion surgery with one of the following bone grafting options:
  • Virtuos with Autograft (local bone)
  • Autograft + allograft (cancellous bone chips)
  • Subject must have a documented diagnosis of DDD. DDD is defined by back and/or radicular pain with degeneration of the disc as confirmed by medical history, physical examination, and radiographic studies that may include CT, MRI, plain X-ray film, discography, myelography, etc. with one or more of the following findings:
  • Instability as defined by >3mm translation or >5 degrees angulation
  • Osteophyte formation of facet joints or vertebral endplates
  • Decreased disc height, on average by >2mm, but dependent upon the spinal level
  • Scarring/thickening of ligamentum flavum, annulus fibrosis, or facet joint capsule
  • Herniated nucleus pulposus
  • Facet joint degeneration/changes; and/or
  • Vacuum phenomenon
  • Subject may have up to a Grade I Spondylolisthesis of the lumbar spine with clinical manifestations of one or more of the following phenomena:
  • Radiculopathy
  • Sensory deficit
  • Motor weakness
  • Reflex changes
  • Subject must require lumbar posterolateral arthrodesis at 1-2 contiguous levels (L1-S1).
  • The number of levels decompressed must equal the number of levels fused.
  • Subject must have been unresponsive to conservative care for at least 6 months prior to fusion surgery.
  • Subject must agree not to use electromagnetic adjuncts to enhance bone fusion during the course of the study
  • Subject must be willing and able to sign an informed consent document.
  • Subject must be willing and able to return for all follow-up visits, agree to participate in postoperative clinical and radiographic evaluations and comply with the required study regimen.

排除标准

  • Exclusion criteria:
  • Subject is under 18 years of age (<18) at the time of consent
  • Subject has had prior lumbar spine fusion surgery at any level
  • Subject has greater than grade 1 spondylolisthesis of the lumbar spine
  • Subject is currently undergoing treatment for malignancy or has undergone treatment for malignancy in the past 5 years (benign skin cancer is permitted)
  • Subject is pregnant (confirmed by pregnancy test) or nursing or planning to become pregnant during the two years (24 months) following arthrodesis
  • Subject has an active local or systemic infection or is undergoing adjunctive treatment for local or systemic infection

结局指标

主要结局

Successful Fusion

时间窗: Twelve months

Fusion status at Twelve months postoperative

次要结局

  • Safety Profile(Twelve and Twenty-four months)
  • Clinical Outcomes(Twelve months)

研究者

发起方
Orthofix Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验